<div id="readability-page-1"><div><p>Insiders who purchased US$165.5k worth of <strong>Callan JMB Inc.</strong> (NASDAQ:CJMB) shares over the past year recouped some of their losses after price gained 14% last week.  However, the purchase is proving to be a costly gamble, since losses made by insiders have totalled US$80k since the time of purchase.</p><p> While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing,  we would consider it foolish to ignore insider transactions altogether. </p> <p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p><h2> Callan JMB Insider Transactions Over The Last Year </h2> <p> In the last twelve months, the biggest single purchase by an insider was when Founder Wayne Williams bought US$51k worth of shares at a price of US$1.65 per share.    That means that even when the share price was higher than US$0.82 (the recent price), an insider wanted to purchase shares.  While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future.  In our view, the price an insider pays for shares is very important.   Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.     </p> <p> Callan JMB insiders may have bought shares in the last year, but they didn't sell any.    You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! </p><p><span> View our latest analysis for Callan JMB </span></p><figure><img height="872" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1899672147-insider-trading-volume-1-dark-2/1781353549636?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1642" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1899672147-insider-trading-volume-1-dark-2/1781353549636"/><figcaption>NasdaqCM:CJMB Insider Trading Volume June 13th 2026</figcaption></figure><p> There are plenty of other companies that have insiders buying up shares. You probably do <strong>not</strong> want to miss this <strong>free</strong> list of undervalued small cap companies that insiders are buying. </p> <h2> Callan JMB Insiders Bought Stock Recently  </h2><p> Over the last three months, we've seen a bit of insider buying at Callan JMB.     Chief Medical Officer  David Croyle  bought US$18k worth of shares in that time.  We like it when there are only buyers, and no sellers.  But in this case the amount purchased means the recent transaction may not be very meaningful on its own.   </p> <h2> Insider Ownership </h2><p> I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders.  Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term.   It's great to see that Callan JMB insiders own 57% of the company, worth about US$2.5m.  This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.  </p><h2> So What Do The Callan JMB Insider Transactions Indicate? </h2><p> Our data shows a little insider buying, but no selling, in the last three months.  The net investment is not enough to encourage us much.     However, our analysis of transactions over the last year is heartening.   With high insider ownership and encouraging transactions, it seems like Callan JMB insiders think the business has merit.      So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing.    When we did our research, we found <strong>4 warning signs for Callan JMB</strong> (2 are significant!) that we believe deserve your full attention.  </p><p> Of course <strong>Callan JMB may not be the best stock to buy</strong>. So you may wish to see this <strong>free</strong> collection of high quality companies. </p><p><em>For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.</em></p><div><h3><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><div><p>• Dividend Powerhouses (3%+ Yield)<br/>• Undervalued Small Caps with Insider Buying<br/>• High growth Tech and AI Companies</p><p>Or build your own from over 50 metrics.</p></div><p>Explore Now for Free</p></div></div></div>

CJMB

<p>Callan JMB insiders remain US$80k below their original investment value despite a recent 14% stock price gain. Over the past year, insiders purchased US$165.5k worth of shares with no sales recorded, including significant buys by Founder Wayne Williams and CMO David Croyle. With high insider ownership at 57%, these transactions suggest confidence in the company's future, although the net investment amount is considered modest.</p>

Callan JMB Insiders Still US$80k Away From Original Investment Value